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note that this finding is controversial. Another way to
determine whether NOD mice are lymphopenic is to
Driven to Autoimmunity:
The Nod Mouse establish whether they allow homeostatic expansion of
transferred T cells. Indeed, transferred TCR transgenic
T cells divide in NOD, but not in congenic NOD.B6 Idd3
hosts. These transfer experiments were done with twoIn the lymphoid system, T cells respond to space or
different TCR transgenic lines. One line was reactiveundercrowding by dividing to maintain their numbers.
against an irrelevant foreign antigen and homeostaticIn this issue of Cell, King et al. (2004) provide evidence
proliferation was observed in the spleen and pancreaticthat this homeostatic proliferation, coupled with ex-
draining lymph nodes of NOD, but not congenic NOD.B6cess production of a cytokine, IL-21, is a key factor in
Idd3 mice. The other TCR transgenic line was reactivesusceptibility to autoimmune diabetes.
against a pancreatic islet antigen, and expansion in the
spleen was evident in NOD, but not NOD.B6 Idd3 hosts.T cell tolerance to self begins in the thymus where T cells
Interestingly, division of these islet-specific cells in thereactive against self-antigens are deleted, and contin-
lymph nodes draining the pancreas was quite robust inues in the periphery where multiple mechanisms, includ-
both NOD and NOD.B6 Idd3 congenics, and was proba-ing deletion and immune regulation, are in place to in-
bly the result of antigen-driven proliferation. Future stud-duce and maintain self-tolerance. The failure to induce
ies will determine whether the outcome of proliferationself-tolerance leads to autoimmunity. The nonobese
of these islet-reactive T cells differs in the two hostsdiabetic (NOD) mouse provides a model to study autoim-
(see Figures 1B and 1C).mune diabetes and multiple genetic loci that control
Further monitoring of T cell homeostasis in NOD micedisease susceptibility have been mapped (Todd and
revealed a modest increase in the percentage of cyclingWicker, 2001). Idd3 is one of the most potent loci and
T cells in NOD compared with NOD.B6 Idd3 mice, sug-replacing the NOD locus with a disease-resistant locus
gesting that T cells in NOD mice were undergoing ho-from B6 mice (NOD.B6 Idd3 congenic) reduces the oc-
meostatic expansion. Interestingly, cycling T cells incurrence of diabetes by 70%. To date, a gene or regula-
NOD mice were found to be cytolytic against islet cellstory region responsible for Idd3 susceptibility has not
and able to cause pathogenesis. Future analysis shouldbeen identified. King and colleagues provide a possible
determine whether this cytolytic activity was islet-spe-candidate within the Idd3 region, namely the cytokine
cific. This is likely, since NOD mice have high numbersIL-21, and propose that autoimmune disease in NOD
of islet-reactive T cells, reflecting defects in thymic dele-mice, as well as organ-specific autoimmune disease in
tion, possibly linked to the Idd5.1 susceptibility locusgeneral, is initiated by lymphopenia (reduced numbers
(Delovitch and Singh, 1997; Kishimoto and Sprent, 2001;of lymphocytes) and compensatory homeostatic expan-
Tian et al., 2001). Because NOD and NOD.B6 Idd3 onlysion of autoreactive T cells driven by excess production
differ at Idd3 and not Idd5.1 or any other susceptibilityof IL-21.
loci that might contribute to thymic defects, thymic ex-It is well established that normal T cells undergo ho-
port of islet-reactive T cells is probably similar in NOD
meostatic proliferation when transferred into lympho-
and NOD.B6 Idd3 mice. Therefore, islet-reactive T cells
penic hosts (hosts that are either genetically T cell defi-
are almost certainly tolerized in the periphery of NOD.B6
cient, or rendered so by irradiation) but not “full,” Idd3 mice (Figure 1).
lymphoreplete hosts (Jameson, 2002). For naive T cells, To gain insight into the mechanisms that render NOD,
this expansion depends on cytokines, such as IL-7, and but not NOD.B6 Idd3 mice autoimmune susceptible,
low-affinity recognition of self-antigen in the host. King and colleagues (2004) investigated the role of IL-21,
Alarmingly, naive T cells undergoing homeostatic expan- encoded in the Idd3 locus. IL-21 is a recently identified
sion become “effector-like” cells expressing effector/ cytokine (Parrish-Novak et al., 2002) belonging to a
memory cell-surface markers, and, most alarmingly, de- group that signals through receptors containing the
velop the ability to rapidly produce inflammatory cyto- common  chain; other cytokines in this group that are
kines, and acquire cytolytic activity. Given the extreme critical for T cell homeostasis include IL-7 and IL-15.
lymphopenic conditions used for the generation of “ef- Previous studies determined that IL-21 in conjunction
fector-like” T cells, it has been difficult to understand with TCR and CD28 stimulation enhances T cell prolifer-
under what circumstances such cells normally arise. ation (Parrish-Novak et al., 2002). Importantly, King et
Some have hypothesized that these T cells could play al. (2004) found that IL-21 was expressed at higher levels
a role in autoimmune disease, especially if T cells with in NOD compared to NOD.B6 Idd3 congenics. In addi-
antigen receptors that are close to a dangerously high tion, there were increased percentages of IL-21 recep-
affinity for self have the advantage in homeostatic tor-positive activated T cells in NOD compared to con-
expansion. Low T cell numbers certainly play a role in trols. Together, these findings suggest that IL-21 signals
BioBreeding rats, another model of spontaneous auto- promote proliferation in vivo. A more detailed analysis
immune diabetes, where development of autoimmunity of IL-21R-positive cells revealed that in NOD mice com-
is known to depend on their extreme lymphopenia (Ra- pared to controls, more of these cells express effector
manathan and Poussier, 2001). cytokines, implying that a subset of IL-21R cells in NOD
King et al. (2004) find that young, disease-free NOD mice have acquired pathogenic function (Figure 1C).
mice are modestly lymphopenic while disease-resistant If NOD mice contain high numbers of IL-21R-positive,
NOD.B6 Idd3 mice are not. It is not clear why NOD mice proliferating T cells, why are they lymphopenic? It turns
out that although IL-21 supports proliferation, it doesshould be lymphopenic, and the authors themselves
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Figure 1. Lymphopenia and IL-21 in Development of Autoimmunity in NOD Mice
(A) Thymic epithelial cells in normal and NOD mice express tissue-specific antigens (TSA) such as insulin and Gad65 (Derbinski et al., 2001).
In normal thymus, most T cells that are reactive against these antigens are deleted while in NOD mice defects in thymic deletion results in
an increase in the percentage of TSA-reactive T cells exported to the periphery (Kishimoto and Sprent, 2001).
(B) In pancreatic lymph nodes of normal, lymphoreplete mice or NOD.B6 Idd3mice, TSA-reactive T cells that escape thymic deletion, can still
be deleted in the periphery. Dendritic cells that have acquired TSA from pancreatic islet cells, present this antigen to TSA-reactive T cells
which divide a couple of times before they die (Heath and Carbone, 2001).
(C) In NOD mice, lymphopenia results in settings where there is less competition for T cells to interact with self-antigen bearing DCs and
acquire growth-promoting cytokines. TSA-reactive T cells in lymphopenic environments might therefore receive a “stronger” signal, which is
enhanced by excess levels of IL-21 (and probably other factors that differ in NOD mice). Such T cells go on to acquire effector functions,
resulting in disease.
not promote survival. In NOD mice, (and to a lesser regulatory regions in NOD and control mice need to
be determined.extent NOD.B6 Idd3 congenics), T cells expressing IL-
21R tend to readily undergo cell death. Although many
of the IL-21R-expressing T cells die, surely some IL- Alena M. Gallegos and Michael J. Bevan
21R-expressing T cells survive and destroy islets. This Howard Hughes Medical Institute
issue can be dissected using islet-specific TCR trans- and the Department of Immunology
genic T cells. It is possible that in lymphopenic settings, University of Washington
T cells receiving strong TCR signals, which would be Box 357370
the case for islet-specific T cells in lymph nodes draining Seattle, Washington 98195
the pancreas, thrive with IL-21 signals.
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